Brevan Howard Capital Management LP Ocugen, Inc. Transaction History
Brevan Howard Capital Management LP
- $12.7 Billion
- Q1 2024
A detailed history of Brevan Howard Capital Management LP transactions in Ocugen, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 69,268 shares of OCGN stock, worth $111,521. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,268Holding current value
$111,521% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OCGN
# of Institutions
88Shares Held
32.8MCall Options Held
518KPut Options Held
345K-
Vanguard Group Inc Valley Forge, PA12MShares$19.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.8MShares$6.12 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$5.17 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.61MShares$4.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.93MShares$3.1 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $349M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...